Herbalife Stock Forecast for 2023 - 2025 - 2030
Updated on 04/23/2024
Herbalife Stock Forecast and Price Target
Herbalife has an average price target of $10.00 recently offered by four notable experts for 2024, which would represent a potential upside of approximately 10.01% from the last closing price in April, 2024 if reached. This potential increase is based on a high estimate of $19.00 and a low estimate of $8.00. Even if you are not interested in HLF stock, you should still be aware of its competitors.
10.01% Upside
Herbalife Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Herbalife's Price has decreased by 100.00%, going from $40.88 to $0.00. In the next year, analysts believe that Fair Value will reach $35.70 – an increase of 100.00%. For the next eight years, the forecast is forFair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WMT Stock Forecast | Walmart Inc | Outperform |
15
|
$60.14 | Buy/Sell | $179.15 | 9.74% |
| PG Stock Forecast | Procter & Gamble | Outperform |
12
|
$160.54 | Buy/Sell | $166.80 | 6.52% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$149.12 | Buy/Sell | $174.55 | 14.00% |
| NESN Stock Forecast | Nestlé | Outperform |
11
|
CHF93.84 | Buy/Sell | CHF115.58 | 17.22% |
| SAN Stock Forecast | Sanofi | Outperform |
16
|
88.17€ | Buy/Sell | 102.80€ | 22.49% |
Herbalife Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Herbalife's Revenue has decreased by 8.65%, going from $5.54B to $5.06B. In the next year, analysts believe that Revenue will reach $5.15B – an increase of 1.75%. For the next seven years, the forecast is forRevenue to grow by 3.88%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TGT Stock Forecast | Target | Outperform |
13
|
$167.11 | Buy/Sell | $153.05 | 13.70% |
| CL Stock Forecast | Colgate-Palmolive Co | Outperform |
18
|
$88.33 | Buy/Sell | $88.97 | 5.29% |
| EL Stock Forecast | Estee Lauder Cos Inc-The | Outperform |
18
|
$147.42 | Buy/Sell | $138.34 | 7.45% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| KMB Stock Forecast | Kimberly-Clark | Hold |
18
|
$128.93 | Buy/Sell | $128.04 | 3.93% |
| RKT Stock Forecast | Reckitt Benckiser Group | Outperform |
12
|
£42.66 | Buy/Sell | £66.68 | 34.79% |
| BAYN Stock Forecast | Bayer | Hold |
5
|
27.32€ | Buy/Sell | 45.15€ | 17.13% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CHD Stock Forecast | Church & Dwight Co Inc | Hold |
11
|
$105.95 | Buy/Sell | $96.90 | -0.24% |
| CLX Stock Forecast | Clorox Co-The | Hold |
16
|
$145.14 | Buy/Sell | $154.18 | 6.79% |
| CAG Stock Forecast | Conagra Brands | Hold |
16
|
$31.10 | Buy/Sell | $30.02 | 2.89% |
Herbalife EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Herbalife's EBITDA has decreased from $740.90M to $523.90M – a 29.29% drop! In the next year, analysts are expecting an increase in EBITDA, predicting it will reach $668.80M – an increase of 27.66%. The Herbalife forecast is for EBITDA to reach $701.40M or grow by 33.88%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| COTY Stock Forecast | Coty Inc | Outperform |
16
|
$11.28 | Buy/Sell | $13.33 | 15.25% |
| BRBR Stock Forecast | BellRing Brands | Outperform |
16
|
$55.08 | Buy/Sell | $52.21 | 14.38% |
| POST Stock Forecast | Post Holdings | Outperform |
16
|
$104.63 | Buy/Sell | $104.78 | 9.91% |
Herbalife EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Herbalife has seen a decline in its EBIT, from $640.60M to $410.60M – a 35.90% decrease. For next year, the 5 analysts predict EBIT of $551.26M, which would mean an increase of 34.26%. Over the next nine years, the pros' prediction is EBITof $575.94M, which would mean a nine-year growth forecast of 40.27%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GL9 Stock Forecast | Glanbia | Outperform |
18
|
17.84€ | Buy/Sell | 16.42€ | 12.11% |
| NTCO3 Stock Forecast | Natura &Co Holding | Outperform |
12
|
R$16.05 | Buy/Sell | R$18.70 | 18.38% |
| PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$30.06 | Buy/Sell | $44.75 | 33.07% |
Herbalife EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Herbalife's EPS has decreased by 100.00%, going from $3.71 to $0.00. In the next year, analysts believe that EPS will reach $3.24 – an increase of 100.00%. For the next eight years, the forecast is forEPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 300146 Stock Forecast | Byhealth | Outperform |
15
|
¥15.53 | Buy/Sell | ¥26.39 | 43.34% |
| SMPL Stock Forecast | Simply Good Foods Co-The | Outperform |
15
|
$32.91 | Buy/Sell | $40.58 | 24.58% |
| 8454 Stock Forecast | momo.com | Hold |
18
|
NT$399.00 | Buy/Sell | NT$608.78 | 23.43% |
.jpg)